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Background: Recent studies demonstrate that diabetic patients treated with coronary stent are associated with the high cardiovascular events 
compared with those without diabetes (DM). However, it remains unknown whether the prognosis of hemodialysis patients may be affected by 
diabetes in the same way. The aim of this study was to examine the impact of diabetes on clinical events in hemodialysis patients with CAD following 
coronary stenting.
Methods: Twenty two hundreds and ninety three patients were underwent coronary stenting (2008.4.1-2009.6.30). Within them, twenty one 
hundreds and sixteen patients without hemodialysis were assigned to two groups with or without diabetes (non HD-DM; n=815; male, 594; age, 
69.1ys,: non HD-non DM; n=1301, male, 976; age, 70.0ys). The other one hundred seventy seven hemodialysis patients were also assigned to two 
groups with or without diabetes (HD-DM; n=53, male, 40; age, 65.3ys,: HD-non DM; n=124; male, 96; age, 68.7ys,). We examined the clinical events 
between four groups, prospectively.
Results: Primary endpoints were defined as all cause of death, nonfatal myocardial infarction, and stroke. There were no differences in clinical 
characteristics between four groups. The ratio of all cause of death were highest in HD-DM compared with HD-non DM, non HD-DM, and non HD-non 
DM (15.1% vs 4.0%, 2.9%, 3.1%, p<0.01), however, there were no differences in the occurrence of non-fatal myocardial infarction and stroke.
Conclusions: Hemodialysis patients with DM exhibited an increased risk of clinical adverse events compared to those without DM and non-
hemodialysis patients. These results indicate that diabetes may be one of the predictors for clinical outcomes even in the hemodialysis patients 
treated with coronary stenting.
